NetworkNewsBreaks – Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Closes $75 Million IPO

July 29, 2019 09:59:45

Mirum Pharmaceuticals (NASDAQ: MIRM), a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, has closed an initial public offering of 5,000,000 shares of its common stock. According to the update, the offering resulted in gross proceeds of $75 million for Mirum Pharmaceuticals, with shares sold at the public offering price of $15.00 each. The shares began trading on the Nasdaq Global Market under the symbol “MIRM” on July 18, 2019. ROTH Capital Partners acted as co-manager for the offering.

To view the full press release, visit

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (“PFIC”) and Alagille syndrome (“ALGS”). For more information, visit the company’s website at

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office